InMode Ltd.
Health
Performance
3.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

InMode Ltd. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

08.07.2026
Calmer waters ahead. Risk signals cooling off.
25.06.2026
Shaky at first, now slowly moving toward steady ground.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
INMD
InMode Ltd.
15.36
+0.00%
3.6
Sell
Buy
InMode Ltd.

InMode Ltd. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does InMode Ltd. do? Business model and key facts

Get the full picture of InMode Ltd.: what it builds, where it operates, and how it makes money.

InMode Ltd. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 660

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

shop
Company facts
Moshe Mizrahy
CEO
660
Employees worldwide
shop
Performance
10.03%
Last 12 months
-72.63%
Last 5 years
shop
Growth
$370.50M
Revenue year
$93.83M
Net income
shop
Valuation
$889.23M
Market Cap
10.13
Price/Earnings Ratio

Stocks related to InMode Ltd.

Selected based on industry alignment and relative market positioning.

PRCT
PROCEPT BioRobotics Corporation
18.52
-3.64%
8.3
Sell
Buy
PROCEPT BioRobotics Corporation
AVNS
Avanos Medical, Inc.
24.98
-0.04%
7.6
Sell
Buy
Avanos Medical, Inc.
AORT
Artivion, Inc.
24.94
-1.69%
7.8
Sell
Buy
Artivion, Inc.
BVS
Bioventus Inc.
11.88
+2.59%
5.3
Sell
Buy
Bioventus Inc.
SIBN
SI-BONE, Inc.
17.04
-0.47%
5.7
Sell
Buy
SI-BONE, Inc.

Events and news impacting InMode Ltd. stock

Earnings, coporate decisions and industry developments that can affect the share price.

InMode Ltd. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.